Skip to content

Sana Biotechnology, Inc.

SANA

CIK 0001770121

← back to feed
Revenue (TTM)
—
Q1 Apr 2026
Net Income (TTM)
−$232.55M
+8.5% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$0.93
+17.2% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
—
Q1 Apr 2026
Net Margin
—
Q1 Apr 2026
Free Cash Flow (TTM)
−$249.39M
Q1 Apr 2026
Cash
$83.8M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
278.29M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings